Singapore markets close in 3 hours 54 minutes

NeuroSense Therapeutics Ltd. (NRSN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.34000.0000 (0.00%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
7,588
7,588
6,416
3,082
2,495
Selling general and administrative
5,714
5,714
7,136
2,505
393
Total operating expenses
13,302
13,302
13,552
5,587
2,888
Operating income or loss
-13,302
-13,302
-13,552
-5,587
-2,888
Interest expense
11
11
15
0
0
Total other income/expenses net
2,394
2,394
1,143
2,700
61
Income before tax
-11,280
-11,280
-12,340
-4,041
-2,828
Income from continuing operations
-11,280
-11,280
-12,340
-4,041
-2,828
Net income
-11,280
-11,280
-12,340
-4,041
-2,828
Net income available to common shareholders
-11,280
-11,280
-12,340
-4,041
-2,828
Basic EPS
-0.94
-
-1.07
-0.65
-0.26
Diluted EPS
-0.94
-
-1.07
-0.65
-0.26
Basic average shares
12,307
-
11,505
6,243
10,944
Diluted average shares
12,307
-
11,505
6,243
10,944